CanadaBis Capital Inc. (CANB.V)
| Previous Close | 0.0850 |
| Open | 0.0850 |
| Bid | 0.0800 x N/A |
| Ask | 0.0850 x N/A |
| Day's Range | 0.0800 - 0.0850 |
| 52 Week Range | 0.0700 - 0.3500 |
| Volume | |
| Avg. Volume | 146,459 |
| Market Cap | 11.752M |
| Beta (5Y Monthly) | 0.11 |
| PE Ratio (TTM) | 2.83 |
| EPS (TTM) | 0.0300 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
CNW GroupCanadabis Capital Unveils New 60%+ Double-Infused Pre-Roll under Dab Bods Brand, Setting New Standard for THC Potency in Canadian Market
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), – Canadabis Capital, and its shareholdings in Stigma Grow a leading innovator in the Canadian cannabis industry, is thrilled to announce the launch of the latest addition to the Dab Bods brand lineup – a ground breaking 60%+ double-infused pre-roll. This new offering sets a new benchmark for THC potency in the Canadian market, catering to cannabis enthusiasts seeking a premium, high-potency experience.
CNW GroupCANADABIS CAPITAL, WITH SUB STIGMA GROW, ANNOUNCES FISCAL Q2 2024 RESULTS HIGHLIGHTED BY CONTINUED POSITIVE ADJUSTED EBITDA(1) AND NET INCOME
CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, is pleased to announce results from our second quarter fiscal 2024, represented by our tenth consecutive quarter generating net revenue. The Company's Financial Statements and Notes, as well as Management's Discussion and Analysis ("MD&A") are filed on SEDAR at www.sedarplus.ca.
CNW GroupCANADABIS CAPITAL CONFIRMS NO MATERIAL CHANGE
At the request of CIRO, CanadaBis Capital Inc. (the "Company" or "CanadaBis") (TSXV: CANB), a premium vertically integrated Canadian cannabis company, wishes to confirm that the Company's management is unaware of any material change in the Company's operations that would account for the recent increase in market activity.
